This menu provides the list of EV proteins identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
UniProt accession
UniProt name
Protein name
Gene symbol
Species
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Escherichia coli
In vitro/In vivo
In vitro
By sample type
Escherichia coli O25b:H4-ST131
By sample status
Gentamicin-sensitive, 0.5 μg/mL gentamicin-treated
Gentamicin-sensitive, 12.0 μg/mL gentamicin-treated
Gentamicin-sensitive, 400 μM 2,2'-bipyridyl (BIP)-treated
Gentamicin-sensitive, 6.0 μg/mL gentamicin-treated
Gentamicin-sensitive, 600 μM 2,2'-bipyridyl (BIP)-treated
Gentamicin-sensitive, control
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Protein name
UniProt accession
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
Probable phosphoglycerate mutase GpmB (EC 5.4.2.-) (PGAM) (Phosphoglyceromutase)
A0A0A1AJ16
Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0406
101
/
7
/
94
[1]